The EFFECT trial: evaluating exacerbations, biomarkers, and safety outcomes with two dose levels of fluticasone propionate/formoterol in COPD.
about
The EFFECT trial: evaluating exacerbations, biomarkers, and safety outcomes with two dose levels of fluticasone propionate/formoterol in COPD.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
The EFFECT trial: evaluating e ...... propionate/formoterol in COPD.
@ast
The EFFECT trial: evaluating e ...... propionate/formoterol in COPD.
@en
type
label
The EFFECT trial: evaluating e ...... propionate/formoterol in COPD.
@ast
The EFFECT trial: evaluating e ...... propionate/formoterol in COPD.
@en
prefLabel
The EFFECT trial: evaluating e ...... propionate/formoterol in COPD.
@ast
The EFFECT trial: evaluating e ...... propionate/formoterol in COPD.
@en
P2093
P2860
P356
P1476
The EFFECT trial: evaluating e ...... propionate/formoterol in COPD.
@en
P2093
Alberto Papi
Kirsten McAulay
Paul W Jones
Prashant S Dalvi
Sanjeeva Dissanayake
Tammy McIver
P2860
P304
P356
10.2147/COPD.S93375
P407
P577
2015-11-09T00:00:00Z